Santen Pharmaceutical Co.’s $225 Million Acquisition Of Eyevance Pharmaceuticals Holdings Inc.

Morrison & Foerster LLP advised Santen Pharmaceutical Co. on the deal. Santen Pharmaceutical Co., Ltd., a company dedicated to ophthalmology, announced its acquisition of Eyevance Pharmaceuticals...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here